<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report two cases of children, 7 and 14 yr old, in whom prolonged infusion of <z:chebi fb="0" ids="102166">thiopental</z:chebi> <z:chebi fb="199" ids="26708">sodium</z:chebi> (TS) was used to control intracranial <z:hpo ids='HP_0000822'>hypertension</z:hpo> previously unresponsive to conventional therapy </plain></SENT>
<SENT sid="1" pm="."><plain>Intracranial <z:hpo ids='HP_0000822'>hypertension</z:hpo> followed removal of a large <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> in 1 case, and trauma in the other </plain></SENT>
<SENT sid="2" pm="."><plain>TS was administered at a rate of up to 7 mg/kg . h for 8 days in 1 patient, and up to 12 mg/kg . h for 10 days in the other </plain></SENT>
<SENT sid="3" pm="."><plain>Both children regained consciousness and made significant recovery of neurological function </plain></SENT>
<SENT sid="4" pm="."><plain>The advantage and the side-effects of the prolonged use of TS for intracranial <z:hpo ids='HP_0000822'>hypertension</z:hpo> are discussed </plain></SENT>
</text></document>